This inventor holds 10 USPTO granted patents and 5 published patent applications and 10 EPO patents. Top assignees: Roche Innovation Center Copenhagen A/s, Santaris Pharma A/s, Other. Active years: 2012-2019.
Location History:
- Malmö, SE (2013 - 2015)
- Stockholm, SE (2012 - 2017)
- Malmo, SE (2012 - 2019)
Company Filing History:
5 out of 46 
4 out of 44 
1 out of 834,307 Years Active: 2012-2019
Title: Innovation and Impact: The Contributions of Joacim Elmen
Introduction
Joacim Elmen, an esteemed inventor based in Malmö, Sweden, has made significant strides in the field of biotechnology. With a portfolio of five patents, his work primarily revolves around the development of novel oligonucleotides aimed at medical applications. His innovative approaches contribute greatly to the understanding and treatment of various diseases.
Latest Patents
Among Joacim Elmen's latest inventions are two notable patents titled "Micromirs" and "MICROMIRs." Both inventions involve very short heavily modified oligonucleotides specifically designed to target and inhibit microRNAs in vivo. These advancements hold considerable promise for their use in medicaments and pharmaceutical compositions, showcasing Elmen's commitment to addressing critical health challenges.
Career Highlights
Elmen's professional journey includes significant roles at well-respected companies in the pharmaceutical sector, particularly at Roche Innovation Center Copenhagen A/S and Santaris Pharma A/S. His experiences in these leading organizations have equipped him with the skills and insights necessary to drive innovation and impact in the field of biomedicine.
Collaborations
Throughout his career, Joacim has collaborated with prominent colleagues, including Susanna Obad and Sakari Kauppinen. These partnerships have facilitated the sharing of ideas and expertise, enhancing the development of groundbreaking technologies in the life sciences.
Conclusion
Joacim Elmen stands as a pivotal figure in the realm of biotech innovation, particularly through his work on oligonucleotides targeting microRNAs. His patents reflect a deep commitment to advancing medical science and improving therapeutic options. As the field continues to evolve, the contributions of inventors like Joacim will undoubtedly play a crucial role in shaping future advancements.